Gladstone Institutional Advisory LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1766530
Bedminster, NJ
Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$1,263,652
+$486,247 QoQ
Shares Held
10,002
+79.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#981
of 2,266 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gladstone Institutional Advisory LLC holds $67,973,516 across 11 Drug Manufacturers - General names. GILD ranks #9 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
19,736 | $23,671,952 | |
| 2 | JNJ |
Johnson & Johnson
|
52,767 | $13,401,234 | |
| 3 | MRK |
Merck & Co., Inc.
|
84,891 | $10,908,493 | |
| 4 | ABBV |
AbbVie Inc.
|
33,122 | $8,334,820 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,905 | $3,912,686 | |
| 6 | AMGN |
Amgen Inc
|
6,692 | $2,423,307 | |
| 7 | PFE |
Pfizer Inc
|
78,104 | $1,880,744 | |
| 8 | NVS |
Novartis AG
|
8,936 | $1,400,449 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,263,652 | 10,002 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $777,405 | 5,578 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,201,133 | 9,786 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,067,820 | 9,620 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $922,327 | 8,319 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $927,325 | 8,276 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $333,917 | 3,615 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $327,311 | 3,904 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $886,303 | 12,918 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $932,912 | 12,736 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,098,090 | 13,555 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,034,696 | 13,807 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,024,722 | 13,296 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,111,217 | 13,393 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,335,053 | 15,551 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $931,457 | 15,099 | Shares | Sole | 2023-01-30 | |
| 2022-06-30 | $860,333 | 13,919 | Shares | Sole | 2023-01-30 | |
| 2022-03-31 | $763,040 | 12,835 | Shares | Sole | 2023-01-30 | |
| 2021-12-31 | $855,708 | 11,785 | Shares | Sole | 2023-01-30 | |
| 2020-09-30 | $328,840 | 5,204 | Shares | Sole | 2023-01-30 | |
| 2020-06-30 | $285,216 | 3,707 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $623,348 | 8,338 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||